Trial Profile
A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 01 Sep 2013 New trial record